drugset / Trial / NCT00562185
Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer
Phase 1/2
Withdrawn
University of Texas Southwestern Medical Center
Ortho Biotech Clinical Affairs, L.L.C. · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy, such as doxorubicin and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving doxorubicin together with carboplatin may kill more tumor cells. PURPOSE: This phase I and phase II trial is studying the side effects and best dose of carboplatin when given together with doxorubicin to see how well it works in treating patients with recurrent ovarian cancer.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | Other |
| Subject | Doxorubicin | Other / unclassified | — | Intravenous |